Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucralfate for Prevention of Delayed Polypectomy Bleeding
NCT05817656Phase 1Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- May 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sucralfate in postpolypectomy bleeding (PPB) (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Incidence rate of delayed polypectomy bleeding at 28 days. Status: unknown.
02
Drugs
sucralfate
03
Conditions
postpolypectomy bleeding (PPB)
Beyond the preview
Go deeper on NCT05817656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05817656.